Inhibiting TIRAP-mediated inflammatory signaling: A promising therapeutic strategy against sepsis
Abstract
The timely therapeutic targeting of the dysregulated immune response in sepsis is essential to restore immune homeostasis and prevent progression to organ dysfunction. In this study, we investigated whether a combination therapy with an antibiotic exhibiting anti-inflammatory properties and the anti-inflammatory compound dorzolamide will improve the bacterial sepsis outcome. Using an in-silico approach, we screened a structure library of FDA-approved antibiotics to identify those that can interact with the Toll/interleukin-1 Receptor (TIR) domain-containing adaptor protein (TIRAP), a protein regulating proinflammatory cytokine production in immune cells. Our virtual screening identified a broad-spectrum antibiotic, levofloxacin, as a candidate. We subsequently employed the cecum slurry (CS) septic mouse model to validate the candidates in vivo, while monitoring survival of mice, tissue mRNA expression, cell morphology, cytokine levels, and other biochemical markers. The in vivo studies confirmed that the combination of levofloxacin and dorzolamide (LeDoz) increased the survival rate of septic mice. Hematoxylin and eosin (H&E) tissue staining, cytokine levels, as well as immunofluorescence dual staining and serum biomarkers, all showed the reestablishment of homeostatic conditions in the LeDoz-treated group of septic mice compared to untreated septic mice. In vitro analyses also confirmed the ability of LeDoz to attenuate TIRAP-mediated inflammatory signaling. Thus, the…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.